ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,714Medicare Part D Prescriptions Filled, Including Refills

Rank: 18 out of 623

$504K Total Retail Price of All Prescriptions

Rank: 36 out of 623

266 Patients Receiving at Least One Drug in Part D
74%Patients 65 Years and Older
74% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Maryland
Lower avg

Schedule Two
Controlled Substances

22% of this provider’s 266 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

11% of this provider’s 266 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

1% of this provider’s 8,416 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $66 among peers.

Prescriptions per Patient

40 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Maryland
LISINOPRIL 368 320 1 1
AMLODIPINE BESYLATE 345 303 2 3
OMEPRAZOLE 335 282 3 7
LEVOTHYROXINE SODIUM 292 272 4 4
SIMVASTATIN 273 203 5 2
FUROSEMIDE 248 238 6 5
OXYCODONE HCL 216 65 S2 7 30
DONEPEZIL HCL 179 167 8 27
CARVEDILOL 177 135 9 32
MIRTAZAPINE 172 149 10 31
KLOR-CON M20 162 162 11 62
LISINOPRIL-HYDROCHLOROTHIAZIDE 151 129 12 19
HYDROCODONE-ACETAMINOPHEN 141 116 S3 13 17
CITALOPRAM HBR 136 116 14 21
GABAPENTIN 135 65 15 18
ZOLPIDEM TARTRATE 133 106 16 22
ALBUTEROL SULFATE 132 132 17 69
LACTULOSE 131 71 18 67
PREDNISONE 130 108 19 40
ESCITALOPRAM OXALATE 129 105 20 60
CYMBALTA 127 68 21 52
SILVER SULFADIAZINE 119 103 22 182
METOPROLOL TARTRATE 116 102 23 9
ECONAZOLE NITRATE 112 99 24 217
METOPROLOL SUCCINATE 109 83 25 13
IPRATROPIUM BROMIDE 106 106 26 133
QUETIAPINE FUMARATE 100 86 27 51
METFORMIN HCL 95 58 28 6
CLOPIDOGREL 92 90 29 34
TAMSULOSIN HCL 92 88 29 35
ATORVASTATIN CALCIUM 90 68 31 10
LEVETIRACETAM 89 89 32 83
TRAMADOL HCL 84 64 33 15
POLYETHYLENE GLYCOL 3350 84 54 33 53
SERTRALINE HCL 82 81 35 20
JANTOVEN 82 82 35 54
SSD 78 56 37 234
OXYCONTIN 77 65 S2 38 137
LEVOFLOXACIN 76 71 39 72
PANTOPRAZOLE SODIUM 76 40 39 26
HYDROCHLOROTHIAZIDE 75 73 41 8
FLUTICASONE PROPIONATE 73 61 42 29
TRAZODONE HCL 70 54 43 36
TRIAMCINOLONE ACETONIDE 69 54 44 130
PLAVIX 68 67 45 46
ATENOLOL 68 66 45 12
OXYCODONE-ACETAMINOPHEN 66 41 S2 47 42
VOLTAREN 65 63 48 153
PRAVASTATIN SODIUM 63 57 49 11
GLIMEPIRIDE 63 63 49 38
LANTUS 62 30 51 41
LOSARTAN POTASSIUM 62 61 51 16
ENDOCET 59 0 S2 53 123
NAMENDA 56 56 54 47
ISOSORBIDE MONONITRATE ER 54 46 55 64
BUPROPION HCL SR 52 50 56 221
SULFAMETHOXAZOLE-TRIMETHOPRIM 51 39 57 78
NOVOLOG 50 30 58 75
FLUOXETINE HCL 50 48 58 84
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 5, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.